Q9954 Oral magnetic resonance contrast agent, per 100 ml
Billable / valid for submission HCPCS Release 2026Q3
Short description: Oral mr contrast, 100 ml
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Oral magnetic resonance contrast agent, per 100 ml | yes |
Related codes in Q99
- Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml
- Q9951 Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9953 Injection, iron-based magnetic resonance contrast agent, per ml
- Q9955 Injection, perflexane lipid microspheres, per ml
- Q9956 Injection, octafluoropropane microspheres, per ml
- Q9957 Injection, perflutren lipid microspheres, per ml
- Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
- Q9959 High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
- Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
- Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
- Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
- Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
- Q9964 High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
- Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
- Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
- Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
- Q9982 Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- Q9983 Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Q9991 Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg